Summary
A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.
Researchers at Queen Mary University of Londons School of Biological and Behavioural Sciences have found that the new TOR inhibitor rapalink-1 can extend the chronological lifespan o…
Source: SciTechDaily
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
